Market Research Logo

CooperVision Inc - Product Pipeline Analysis, 2017 Update

Summary

CooperVision Inc (CooperVision), a subsidiary of The Cooper Companies Inc, designs and manufactures soft contact lenses. It manufactures a wide array of monthly, two-week and daily disposable contact lenses. CooperVision helps overcome various vision challenges such as astigmatism and presbyopia; and offers a comprehensive collection of spherical, toric and multifocal products. The company offers its products under various categories such as MyDay, clariti 1 day family and Biofinity family to meet the requirements of people with different types of vision problems. The company provides information regarding eye problems, eye health and supplements. It also provides instructions and information related to wearing contact lenses and their care. CooperVision is headquartered in Victor, New York, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company CooperVision Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


CooperVision Inc Company Overview
CooperVision Inc Company Snapshot
CooperVision Inc Pipeline Products and Ongoing Clinical Trials Overview
CooperVision Inc – Pipeline Analysis Overview
CooperVision Inc - Key Facts
CooperVision Inc - Major Products and Services
CooperVision Inc Pipeline Products by Development Stage
CooperVision Inc Ongoing Clinical Trials by Trial Status
CooperVision Inc Pipeline Products Overview
Biofinity Energys
Biofinity Energys Product Overview
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens Product Overview
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens Clinical Trial
MyDay Toric
MyDay Toric Product Overview
SiH Multifocal
SiH Multifocal Product Overview
CooperVision Inc - Key Competitors
CooperVision Inc - Key Employees
CooperVision Inc - Locations And Subsidiaries
Head Office
Recent Developments
CooperVision Inc, Recent Developments
Dec 13, 2017: CooperVision Announces Nationwide Availability of Expanded Parameters for Avaira Vitality toric
Sep 13, 2017: LensFerry Now Offers EHR Integration; Automation Drives Practice Revenue
Sep 07, 2017: Together We’ve Made Biofinity Energys a Breakthrough Success
Jun 10, 2017: Three-year study says new contact lens therapy slows myopia progression in children by 59 percent
Jun 10, 2017: Three-Year Study Indicates Pioneering Contact Lens Therapy Effective in Slowing Myopia Progression in Children by 59%
Jun 05, 2017: CooperVision Receives Environmental Innovative Project of the Year, 12 Additional Environmental Sustainability and Occupational Health & Safety Honors
Apr 27, 2017: CooperVision Issues Call for Proposals for 5th Annual Science and Technology Awards Program
Mar 31, 2017: LensFerry S Adds Online Enrollment for Patient Ease-of-Purchase
Mar 30, 2017: CooperVision Becomes First Major Contact Lens Manufacturer to Join The Vision Council
Mar 27, 2017: CooperVision Affirms UPP on Biofinity Energys
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
CooperVision Inc Pipeline Products and Ongoing Clinical Trials Overview
CooperVision Inc Pipeline Products by Equipment Type
CooperVision Inc Pipeline Products by Indication
CooperVision Inc Ongoing Clinical Trials by Trial Status
CooperVision Inc, Key Facts
CooperVision Inc, Major Products and Services
CooperVision Inc Number of Pipeline Products by Development Stage
CooperVision Inc Pipeline Products Summary by Development Stage
CooperVision Inc Ongoing Clinical Trials by Trial Status
CooperVision Inc Ongoing Clinical Trials Summary
Biofinity Energys - Product Status
Biofinity Energys - Product Description
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Product Status
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Product Description
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - A Multi-center Dispensing Clinical Evaluation of MiSight Lenses
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Efficacy and Safety of MiSight Contact Lenses in Reducing the Progression of Childhood Myopia, Not Pathological, Aged 8-12 Years Randomized Clinical Trial
MyDay Toric - Product Status
MyDay Toric - Product Description
SiH Multifocal - Product Status
SiH Multifocal - Product Description
CooperVision Inc, Key Employees
Glossary
List of Figures
CooperVision Inc Pipeline Products by Equipment Type
CooperVision Inc Pipeline Products by Development Stage
CooperVision Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report